Berna Biotech Pharma and Swiss Biotech Center to develop second-generation covid-19 vaccine

Swiss biotech companies Berna Biotech Pharma and Swiss Biotech Center are joining forces to develop a second-generation vaccine against covid-19. The goal is to conduct clinical trials by fall 2021.

Berna Biotech Pharma and Swiss Biotech Center have signed a strategic collaboration agreement for the development of a vaccine against covid-19. The vaccine, which has demonstrated impressive efficacy in vivo models, is based on a human cell line platform expressing structural glycoproteins with immunogenic carrier virus-like particles. VLPs are molecules that closely resemble viruses, but contain no genetic material and are therefore non-infectious and unable to multiply.

Berna Biotech Pharma’s origins date back to the Swiss Serum and Vaccine Institute, founded in 1898. By the early 2000s, the company was one of the top five vaccine companies globally, producing more than 20 different vaccines. The Swiss Biotech Center has recognized know-how in the development of biopharmaceuticas. Its pre-industrial platform supports the development of innovative products, from the idea to the final product.

Besides working on a covid-19 vaccine, the two partners want to extend their collaboration to revive vaccinology in Switzerland. In the medium term, they plan to produce and commercialize more than 15 vaccines, on a production site with the latest technologies in advanced biomanufacturing and Industry 4.0.

More Stories about Greater Geneva Bern area

HubsGoGlobal is a platform under the PharmaBoardroom brand that focuses on the competitive advantages of the Hub and its value proposition in terms of strategic, operational, financial, talent and lifestyle aspects.

PharmaBoardroom provides industry trends, news and reports from all over the world. This site is for senior professionals who want to understand local and global markets.


Greater Geneva Bern area is an initiative of the cantons of
Bern, Fribourg, Vaud, Neuchâtel, Geneva and Valais.

World Trade Center – Av. de Gratta-Paille 2
PO Box 252
1000 Lausanne 22 – Switzerland


Copyright: All rights reserved. No part of this site maybe reproduced in any form or by any means, whether electronic, mechanical or otherwise including photocopying, recording or any information storage or retrieval system without prior written consent of PharmaBoardroom. While every attempt is made to ensure the accuracy of the information contained in this website, neither PharmaBoardroom nor the authors accept any liabilities for errors and omissions. Opinions expressed in this report are not necessarily those of the authors.

2021 © PharmaBoardroom